In a brief statement, Swedish biotech firm Q-Med said it has received a $502 million offer from from Ivytan, a firm owned by private equity group EQT V and Lyftet Holding. "The Board will evaluate all aspects of Ivytan's offer and will make any decisions that the situation may require," the company said in a statement. Q-Med develops and markets medical implants.
- see the release